The World Health Organization (WHO) just declared mpox to be a global health emergency. But don't expect it to turn into the ...
A National Institutes of Health (NIH)-funded clinical trial of an mpox vaccine in adolescents found it was safe and generated an antibody response equivalent to that seen in adults, according to a ...
A new, more infectious strain of the potentially deadly mpox virus has been found in Germany for the first time, health chiefs in the country have said. The Robert Koch Institute (RKI), Germany's ...
Two confirmed cases of mpox virus, formerly known as monkeypox, are in El Paso, according to the El Paso Department of Public Health. Two men in their 40s, who reside in the same household ...
Mpox (formerly known as monkeypox) is a viral disease caused by the monkeypox virus, which belongs to the same family of viruses as smallpox. Few new cases emerged in India this year during ...
KAMPALA, Uganda (AP) — The number of mpox -related deaths in Africa has surpassed 1,000, the head of the continent’s top public health agency said Thursday, warning of the continuing threat of ...
WHO says it has been identified in Burundi, Kenya, Rwanda and Uganda – all countries that have never reported cases of mpox before. The public health emergency was declared by the group’s ...
Your support makes all the difference. A deadly new variant of the Mpox virus has been detected in the UK after months of growing concerns as it spread through countries in Africa, and was ...
Oct 14 (Reuters) - The World Health Organization said on Monday it had approved Bavarian Nordic's (BAVA.CO), opens new tab mpox vaccine for adolescents aged 12 to 17 years, an age group considered ...
The World Health Organization (WHO) announced on Oct 4 (2024) that it had approved the use of the first diagnostic test for mpox, a key tool for countries battling outbreaks of this infectious ...
A clinical trial of an mpox vaccine in adolescents found it was safe and generated an antibody response equivalent to that seen in adults, according to a planned interim analysis of study data.